Singapore develops robot for collecting swab samples
Singapore has developed a robot that carries out nasal swabbing to diagnose Covid-19 in a bid to reduce healthcare workers’ risk of exposure to the deadly coronavirus.
Clinicians from the National Cancer Centre Singapore (NCCS) and Singapore General Hospital (SGH) have partnered with Biobot Surgical, a firm specializing in medical robotics technology, to develop SwabBot.
The self-administered robot, that automates the collection of Covid-19 swab tests, will help reduce healthcare workers’ risk of exposure to the coronavirus, it said.
The robot helps address the limitations of manual swab tests by reducing the need for trained manpower, standardizing the consistency of the swabs taken and “providing greater throughput” of swab tests as the robot does not suffer from fatigue, the three groups said in a statement.
SwabBot is a “self-administered” robot, meaning patients can activate and terminate the process at will. When a patient is ready, they can use their chin to activate the robot and start the swabbing process.
The robot then extends the swab through the nose to the back of the nasal cavity, which is typically about 10cm from the nostrils.